TrilliumBiO was pleased to attend Annapolis Day 2026, the advocacy summit and leadership reception hosted by the Maryland Tech Council.

Kaustabh Basu, Associate Director, Business Development & Translational Medicine at TrilliumBiO, moderated the panel “Keeping Cures Within Reach: Maryland’s Path on Rare Disease.”

Panelists included:

• Alan Freeman, Esq., Chief Strategy Officer and General Counsel, Uncommon Cures
• Michael States, a rare disease advocate & patient